David Haefliger

5PUBLICATIONS
26CO-AUTHORS
PharmacogenomicsMotor controlMicrofluidics and nanofluidicsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 24, 2026
Ruxolitinib Pharmacokinetics and Exposure-Toxicity Relationship in Hematologic Malignancies and Immune-Mediated Diseases: A Prospective Observational Study.

|Dec 27, 2025
Levetiracetam-induced rhabdomyolysis: a rare adverse effect in a patient with status epilepticus.

Lorane Crausaz, Thomas Baumgartner, David Haefliger

|Nov 25, 2025
Population Pharmacokinetics of Levosimendan and its Metabolites OR-1855 and OR-1896 in Critically Ill Adults, Neonates and Infants on Veno-Arterial ECMO.

Stéphane Bertin, Monia Guidi, David Haefliger

|Jan 17, 2025
Individualization of piperacillin dosage based on therapeutic drug monitoring with or without model-informed precision dosing: a scenario analysis.

David Haefliger, Lynn Mina, Monia Guidi

|Jan 15, 2025
[Teratovigilance. Antiepileptics during pregnancy and paternal use].

Kim Dao, Léonore Diezi, David Haefliger

Pageof 1

Frequent Collaborators

3 joint publications

François R Girardin

3 joint publications

Monia Guidi

3 joint publications

Laurent A Decosterd

2 joint publications

Paul Thoueille